A new clinical trial investigating the use of umbilical cord stem cells to treat chronic heart failure is currently underway. The Phase II trial, which is the first of its kind in the U.S., is being carried out by researchers at the University of Louisville. It’s also...
Last week it was announced that a new gene editing stem cell therapy for beta thalassemia would start to be made available on the NHS. The therapy, called Casgevy, is developed by Vertex Pharmaceuticals and CRISPR Therapeutics and received approval from the UK...
Emerging research suggests that stem cell-based therapies could offer a new approach to treating influenza-related lung damage. Mesenchymal stem cells (MSCs) in particular have been shown to repair lung tissue and modulate the immune response, providing hope for...
The results from a Phase I/II clinical trial suggests a new stem cell-based therapy has the power to treat osteoarthritis (OA). The trial, which was conducted by Australian biotechnology company Magellan Stem Cells, demonstrated that their ‘off-the-shelf’ stem cell...
Five-year-old Gunner Lewis-Vale from Shropshire is finally able to step outside and enjoy the summer for the first time in six months, thanks to a successful stem cell transplant from umbilical cord blood donated 15 years ago. [1] [2] [3] Gunner’s Story At...
New research has emerged showing that a stem cell-derived therapy may be able to treat the most common, and deadliest, form of liver cancer. Scientists at the University of California, San Diego (UCSD) have developed a therapy using natural killer (NK) cells derived...
